September 28, 2016 2:49 AM ET

Healthcare Providers and Services

Company Overview of St. Michael's Hospital

Company Overview

St. Michael's Hospital owns and operates a hospital that provides healthcare services. It offers physical, emotional, and spiritual care services; onsite services; and specialized programs, clinics, inpatient care units, and professional services, as well as tests, laboratory, and imaging services. The company also operates a teaching and research hospital for students from nursing, research, medicine, and health disciplines. It partners with Hospital Collaborative on Vulnerable and Marginalized Populations, South East Toronto Organization, Health Equity Council, Women's College Hospital Uninsured Network, and Toronto Harm Reduction Task Force. St. Michael's Hospital was founded in 1892 and ...

30 Bond Street

Toronto, ON M5B 1W8

Canada

Founded in 1892

Phone:

416-360-4000

Fax:

416-864-5870

Key Executives for St. Michael's Hospital

Chief Executive Officer, President, and Director
President of St. Michael's Foundation
Chief Medical Officer and Executive Vice President
Chief Nursing Executive, Interim Chief Health Disciplines Executive, Executive Vice President of Programs, and Director
Vice President of Research
Compensation as of Fiscal Year 2016.

St. Michael's Hospital Key Developments

Edge Therapeutics Announces Multi-Year Research and Discovery Collaboration with St. Michael's Hospital

Edge Therapeutics announced a multi-year research and discovery collaboration with St. Michael's Hospital. The collaboration will focus on new therapeutic approaches for the treatment of various acute neurological conditions resulting from neurovascular instability. This discovery collaboration brings together Edge's scientific expertise in neurovascular disease with the research and high-throughput drug screening resources of St. Michael's Hospital. Initially the collaboration will focus on using validated models of intracerebral hemorrhage, cavernous malformations, and traumatic brain injury developed by St. Michael's to rapidly screen libraries of compounds for therapeutic activity, and to identify and optimize lead candidates for Edge's early stage pipeline. As previously announced, Edge Therapeutics has initiated patient enrollment in the third cohort of its NEWTON (Nimodipine microparticles to Enhance recovery While reducing TOxicity after subarachNoid hemorrhage) study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of its lead product candidate EG-1962. The NEWTON study is evaluating the safety, tolerability and pharmacokinetics of EG-1962 compared to the current standard of care, oral nimodipine, in patients with aneurysmal subarachnoid hemorrhage (aSAH). Edge is also investigating a second compound, EG-1964, for prevention of recurrence of chronic subdural hematoma. The company plans to submit an IND for that treatment in 2015.

Similar Private Companies By Industry

Company Name Region
2275518 Ontario Inc. Americas
3284733 Nova Scotia Limited Americas
682202 B.C. Ltd. Americas
729759 Alberta Ltd Americas
911 Industrial Response Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact St. Michaels Hospital, please visit www.stmichaelshospital.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.